Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Bevacizumab in Diabetic Vitrectomy
NCT00596297Phase 2Completed
- Sponsor
- Universidade de São Paulo
- Start
- Nov 2007
- Primary completion
- Sep 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in diabetic retinopathy (DR), Vitreous hemorrhage (VH), sponsored by Universidade de São Paulo. Started Nov 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
diabetic retinopathy (DR)Vitreous hemorrhage (VH)
Beyond the preview
Go deeper on NCT00596297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00596297.